The 'Jolie Effect' Was A Game-Changer For Breast Cancer, But It Was Just A Start

Five years ago this Monday, actress and humanitarian Angelina Jolie announced to the world in a New York Times op-ed that she is a BRCA1 gene mutation carrier, and that she underwent a preventative double mastectomy to help reduce her breast cancer risk. BRCA1 and BRCA2 are tumor-suppressing genes, and mutation…
Health

Leave a Reply

Your email address will not be published. Required fields are marked *

*